GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,208,000 | +0.1% | 121,440 | +1.6% | 0.02% | +8.7% |
Q1 2022 | $5,204,000 | -0.6% | 119,486 | +0.7% | 0.02% | +4.5% |
Q4 2021 | $5,233,000 | -12.8% | 118,675 | -24.4% | 0.02% | -18.5% |
Q3 2021 | $5,999,000 | -4.4% | 157,010 | -0.4% | 0.03% | -3.6% |
Q2 2021 | $6,275,000 | +10.6% | 157,587 | -0.8% | 0.03% | +16.7% |
Q1 2021 | $5,672,000 | -9.5% | 158,900 | -6.7% | 0.02% | -11.1% |
Q4 2020 | $6,268,000 | -14.1% | 170,359 | -12.1% | 0.03% | -25.0% |
Q3 2020 | $7,294,000 | -9.6% | 193,788 | -2.1% | 0.04% | -16.3% |
Q2 2020 | $8,070,000 | +0.2% | 197,875 | -6.9% | 0.04% | -10.4% |
Q1 2020 | $8,054,000 | -24.9% | 212,576 | -6.8% | 0.05% | -4.0% |
Q4 2019 | $10,720,000 | +9.2% | 228,025 | -0.9% | 0.05% | +2.0% |
Q3 2019 | $9,821,000 | +5.3% | 230,061 | -1.3% | 0.05% | 0.0% |
Q2 2019 | $9,325,000 | -4.6% | 233,029 | -0.3% | 0.05% | -3.9% |
Q1 2019 | $9,773,000 | +8.1% | 233,826 | -1.2% | 0.05% | -1.9% |
Q4 2018 | $9,040,000 | -10.7% | 236,606 | -6.1% | 0.05% | +2.0% |
Q3 2018 | $10,122,000 | +2.3% | 251,992 | +2.6% | 0.05% | -3.8% |
Q2 2018 | $9,898,000 | +5.1% | 245,549 | +1.9% | 0.05% | +3.9% |
Q1 2018 | $9,414,000 | +6.2% | 240,931 | -3.6% | 0.05% | +10.9% |
Q4 2017 | $8,863,000 | -74.0% | 249,871 | -70.2% | 0.05% | -75.1% |
Q3 2017 | $34,042,000 | +212.7% | 838,476 | +232.1% | 0.18% | +189.1% |
Q2 2017 | $10,887,000 | +5.1% | 252,475 | +2.7% | 0.06% | +1.6% |
Q1 2017 | $10,362,000 | +15.9% | 245,771 | +5.9% | 0.06% | +12.5% |
Q4 2016 | $8,940,000 | -16.0% | 232,171 | -5.9% | 0.06% | -17.6% |
Q3 2016 | $10,641,000 | +12.5% | 246,725 | +13.1% | 0.07% | +6.2% |
Q2 2016 | $9,458,000 | +16.9% | 218,216 | +9.3% | 0.06% | +16.4% |
Q1 2016 | $8,089,000 | -0.0% | 199,665 | -0.5% | 0.06% | +1.9% |
Q4 2015 | $8,092,000 | -0.9% | 200,758 | -5.6% | 0.05% | -3.6% |
Q3 2015 | $8,168,000 | -2.1% | 212,610 | +6.0% | 0.06% | +12.0% |
Q2 2015 | $8,340,000 | -10.9% | 200,645 | -1.0% | 0.05% | -13.8% |
Q1 2015 | $9,358,000 | +27.5% | 202,734 | +18.0% | 0.06% | +26.1% |
Q4 2014 | $7,342,000 | -10.1% | 171,785 | -3.3% | 0.05% | -11.5% |
Q3 2014 | $8,166,000 | +283.6% | 177,615 | +346.2% | 0.05% | -41.6% |
Q2 2014 | $2,129,000 | -0.7% | 39,806 | -0.8% | 0.09% | 0.0% |
Q1 2014 | $2,144,000 | -1.8% | 40,131 | -1.8% | 0.09% | -2.2% |
Q4 2013 | $2,183,000 | +4.4% | 40,885 | -1.8% | 0.09% | -9.0% |
Q3 2013 | $2,090,000 | +5.4% | 41,649 | +4.9% | 0.10% | +4.2% |
Q2 2013 | $1,983,000 | – | 39,685 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |